Claremont Creek Ventures

Claremont Creek Ventures is a seed and early-stage venture capital firm investing in digital solutions that transform essential, broad-impact industries.

About Claremont Creek Ventures

Claremont Creek Ventures is a seed and early-stage venture capital firm, founded by experienced to partner with other entrepreneurs in building ambitious, exceptional technology companies. 

Digital Meets Essential Industries

We invest in digital solutions with the potential to transform essential, broad-impact industries such as and energy. These large industry sectors have historically been slow to adopt emerging technologies in mobility, big data analytics, edge intelligence and user-centric design. CCV is committed to partnering with a new generation of technology creating high-growth, high-margin and capital efficient businesses in these sectors. Our portfolio companies deliver products and services that help these industries enjoy the faster speed-to-market, lower cost structure, greater transparency and creative potential of digitization.

Active, Early-Stage Investing

We practice “Lifecycle Venturing” by building active and meaningful relationships with entrepreneurs alongside or even ahead of early-stage events. Our preference is to lead the earliest investment round, allowing us to collaborate with entrepreneurs when their business concept is still evolving, their operating model is adaptable, and our capital and operating expertise can be most useful. We then help establish business partnerships and build strong syndicates with premier venture and corporate investors to successfully navigate each phase of growth.  

Our Experience 

We approach venture investing with an operator's perspective. Our team has decades of management and product experience building high-growth technology companies. This gives us a collaborative mindset that anchors the relationships we build with every entrepreneur in the CCV portfolio.

Our Team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

click to read bios

Nat Goldhaber

Managing Director ...

Randy Hawks

Managing Director ...

Brad Webb, PhD

Venture Partner ...

Gianna Conci Orozco

Finance Manager ...

Portfolio

Cureus is the medical journal for a new generation of both doctors AND patients. Leveraging the power of an online, crowd-sourced community platform, Cur?us promotes medical research by offering tools that better serve and highlight the people who create it, resulting in better research, faster publication and easier access for everyone.
DNAnexus - a pioneer in cloud-based solutions for large-scale DNA data management and analysis, was designed to accelerate basic science and clinical breakthroughs by providing a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The platform provides labs of any size a secure and compliant cloud platform that supports the unlimited scaling of computational and storage resources.
EcoFactor 's automated service can save 20-40% of HVAC energy use without sacrificing comfort, and gives utilities a more powerful and cost-effective tool for demand management.
Fluxion Biosciences has developed the revolutionary CellFlux microfluidics technology for conducting critical research and drug discovery at the cellular level. The CellFlux platform delivers a robust, high-performance, economical solution for single-cell analysis.
Genalyte has developed and is commercializing a laboratory protein and nucleic acid detection system based on revolutionary microring sensor technology.  Unlike older systems, this new approach to biomarker detection uses a silicon chip containing arrays of photonic ring sensors that reduce or eliminate sample preparation and provide scalable multiplexing for both proteins and nucleic acids in rapid time periods. The one-step workflow of the system can deliver accurate results in as little as 10 minutes from small sample volumes. It has a large dynamic range and excellent sensitivity with outstanding reproducibility.
Natera is a leading genetic testing company in prenatal care, offering a simple, non-invasive and comprehensive maternal blood test to identify fetal genetic abnormalities.  Natera provides a host of preconception and prenatal genetic testing services, including pre-implantation genetic diagnosis, carrier screening, screening of fetal chromosomal anomalies, and conception testing to understand cause of pregnancy loss after a miscarriage.  What's novel and unique is its proprietary -based technology (NATUS) to deliver accurate and comprehensive high-throughput testing for reproductive indications from tiny quantities of DNA.
Numedii, Inc. has developed IT technologies that scour enormous public and private drug and disease databases to unearth novel drug candidates that will have a higher probability of therapeutic success when incorporated into a pharmaceutical development plan. The company uses its Big Data technology to translate these novel disease-drug discoveries into new indications for existing drugs and optimal indications for drugs in development. The company partners with pharmaceutical companies for the clinical development and commercialization of its newly discovered drug candidates.
Renewable Funding develops innovative finance and technology solutions designed to transform America's economy to clean energy.
Trove (formerly Yerdle) is a people-powered store with the best prices on earth. Our inventory is the billions of useful items sitting idle in homes and storage spaces. On TROVE, you post items to earn credits and shop for what you want. Together, we make it easy to save money and reduce waste. Shop Freely!

EXITS

Alter G (formerly Tibion) is a medical device company in the orthopedic space developing active orthotic devices to improve the quality of life for the mobility impaired – those with loss of muscle function due to disease, injury, aging, or surgery.
Assurerx Health has developed a pharmacogenomic test to assist physicians in evaluating and choosing the right medications for their patients who have mental health conditions. Assurex Health is a recognized leader in , the use of genomic data for better health care. The proprietary technology the company has developed is based on , the science and understanding of genetic factors that influence response to drug treatments. - AssureX/Genesight- acquired by Myriad
Comfy is changing the way people interact with their workplaces. With deep roots in advanced computing and thoughtful user experience, our Oakland-based team of nerds dreams up unconventional software solutions for everyone, from the people who operate the building to the people who fill it. - Comfy - acquired by Siemens
ecoATM is the first company to create an automated self-serve kiosk system that uses patented, advanced machine vision, electronic diagnostics, and artificial intelligence to evaluate and buy-back used electronics directly from consumers for cash or store credit. - EcoATM - acquired OuterWall
Element Energy develops leading-edge technology for the management of multi-cell battery systems.  Their initial product is a cost effective hardware/software system that manages large lithium battery packs. - acquired by Volterra
GeneWEAVE Inc. is a clinical diagnostics company addressing multi-drug-resistant organisms (MDRO). The Company's Smarticles™ technology is a new class of molecular diagnostics that can quickly detect MDROs and assess antibiotic susceptibility directly from clinical samples. - GeneWeave - acquired by Roche
Lefora (f.k.a. Meetro) provides an online forum service that enables anyone to easily create elegant, searchable, media rich online disucussion forums. Lefora has been acquired by CrowdGather. - LEFORA - acquired CrowdGather
ecoATM is the first company to create an automated self-serve kiosk system that uses patented, advanced machine vision, electronic diagnostics, and artificial intelligence to evaluate and buy-back used electronics directly from consumers for cash or store credit.
Natera is a leading genetic testing company in prenatal care, offering a simple, non-invasive and comprehensive maternal blood test to identify fetal genetic abnormalities. Natera provides a host of preconception and prenatal genetic testing services, including pre-implantation genetic diagnosis, carrier screening, screening of fetal chromosomal anomalies, and conception testing to understand cause of pregnancy loss after a miscarriage. What's novel and unique is its proprietary bioinformatics-based technology (NATUS) to deliver accurate and comprehensive high-throughput testing for reproductive indications from tiny quantities of DNA. - Natera - IPO (NTRA)
PropertyBridge is a leading provider of electronic payment processing services for the real estate management industry, offering an integrated, flexible infrastructure that makes it easy for property managers to build secure, friendly online payment solutions. PropertyBridge, CCV's first investment, has been -  acquired by MoneyGram.
ShotSpotter develops gunshot and weapons-fire location systems and technologies which it sells in the law enforcement, homeland security, and military markets. The company's flagship law enforcement product reports the precise location of gunfire to police within seconds, thus producing countless arrests and numerous saved lives.
SmartZip Analytics is a national leader in predictive marketing solutions for real estate and related industries. Using patent-pending home intelligence, predictive analytics and automated marketing campaigns, SmartZip's SmartTargeting platform offers an integrated solution that identifies top prospects accurately and helps reach them through precisely targeted online and offline marketing channels. In addition, leading national real estate companies, including Realtor.com, Homes.com, Foreclosure.com, ZipRealty.com, HomeSnap.com, RealtyStore.com and others rely on SmartZip's best-of-breed analytics for their online businesses.
Zipline Medical is developing a family of products designed to expedite the skin closure procedure every surgon must perform. Sutures are typically considered the gold standard with regards to to scarring, but their use is time-consuming. Surgical staples save considerable operative time, but can leave "track marks" leading to an inferior scar as compared to suture closure. Zipline Medical's skin closure technology combines the advantages of sutures (less scarring) and staples (speed) and enables fast and precise closure with excellent cosmetic results. The technology can be used for closure of surgical incisions and skin biopsies, and for post-surgical pain control. - ZipLine - acquired by Striker

Contact Us

Claremont Creek Ventures
1423 Broadway, PMB 121
Oakland, CA  94612
(510) 740-5001

For Entrepreneurs

If you are starting or building a company that you feel would be a good fit with Claremont Creek, we welcome the opportunity to explore a relationship.  Given the volume of plans we receive, we find that the best way to begin a dialogue is through a personal introduction – a fellow entrepreneur, angel investor, venture capitalist, attorney or someone we know in common who understands our investment process. 

 

**Disclaimer: Do not submit any information or other materials that you consider to be confidential or proprietary. Because of the large number of business plans and related materials that we review, and the similarity of many such plans and materials, we cannot accept responsibility for protecting against misuse or disclosure of any confidential or proprietary information or other materials in the absence of our express written agreement to do so.

For Press

Press contact: Jennifer Jones jennifer@jenniferjones.com 650-465-5831

 

Driving Directions

Directions from the South Bay:

Take I-880 North to Oakland.
Follow I-980 E toward Walnut Creek.
Take the 11th Street .
Follow Castro Street to 14th St./International Dr.
Turn right onto 14th St./International Dr.
Turn Left on Clay.
Closest Parking is on 14th and Clay.

Directions from San Francisco:

Take I-80 East to Oakland.
Follow the I-580 E ramp to Downtown Oakland.
Bear Right onto the I-980 W ramp to Downtown Oakland.
Take the 18th Street Exit towards 14th St.
Turn Left on 17th Street.
Closest Parking is on 17th and San Pablo.

Directions from the East Bay:

From I-680 take CA-24 W to Downtown Oakland.
CA-24 turns into I-980.
Continue on I-980 W to Downtown Oakland.
Take the 18th Street Exit.
Turn Left on 17th Street.
Closest Parking is on 17th and San Pablo.

BART Directions:

Take BART to 12th St. Oakland City Center.
When exiting the BART Station, exit towards "Frank H. Ogawa Plaza" (towards the back of the BART station).
Take the escalator up and walk straight ahead through the plaza (away from Broadway).